Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NBIS vs GSK✓SelectedUSD · GSKNBIS vs GSK performance historyLatest closeAs of-1.02%11/17
Stock and ETF performance explorer

NBIS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+23.3%
GSK return
+7.1%
Excess return
+16.2%
Maximum drawdown
-63.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.0%-2.3%+1.3%-2.7%
7D-20.9%-3.0%-17.9%-22.5%
30D-35.9%+0.4%-36.3%-35.3%
3M-60.6%-1.2%-59.4%-60.0%
6M-51.8%+0.9%-52.7%-50.6%
YTD+26.7%+4.0%+22.7%+36.9%
1Y+23.3%+7.3%+16.0%+36.5%
All+23.3%+7.1%+16.2%+36.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling